ArticleClinical and translational science2022

Translational findings for odronextamab: From preclinical research to a first-in-human study in patients with CD20+ B-cell malignancies.

Min Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.